Dyne Therapeutics, Inc.
Company Information
Industry
Pharmaceutical Preparations
SIC Code
2834
Entity Type
operating
SEC Category
Large accelerated filer
State of Incorporation
DE
Business Address
1560 TRAPELO ROAD, WALTHAM, MA, 02451
Mailing Address
1560 TRAPELO ROAD, WALTHAM, MA, 02451
Phone
(781) 786-8230
Fiscal Year End
1231
EIN
364883909
Financial Overview
FY2025
$1.19B
Total Assets
$972.13M
Stockholders' Equity
$-3.37
EPS
Recent SEC Filings
| Form Type | Date Filed | Document |
|---|---|---|
| 4 Insider stock transaction report | April 1, 2026 | View on SEC |
| SCHEDULE 13G/A Passive ownership amendment | March 26, 2026 | View on SEC |
| 4 Insider stock transaction report | March 13, 2026 | View on SEC |
| 4 Insider stock transaction report | March 13, 2026 | View on SEC |
| 4 Insider stock transaction report | March 11, 2026 | View on SEC |
| 4 Insider stock transaction report | March 10, 2026 | View on SEC |
| 4 Insider stock transaction report | March 6, 2026 | View on SEC |
| 4 Insider stock transaction report | March 6, 2026 | View on SEC |
| 4 Insider stock transaction report | March 6, 2026 | View on SEC |
| SCHEDULE 13G/A Passive ownership amendment | March 6, 2026 | View on SEC |
Annual Reports
10-K
March 2, 2026
- Proprietary FORCE™ platform for precise delivery of therapeutic payloads to muscle tissue.
- Advanced DYNE-101 (DM1) Phase 1/2 NURTURE trial with promising early biomarker and functional endpoint data.
Insider Trading
STRONG SELL
5 insiders
14 recent transactions
View Full Insider Trading Profile
Related Companies
Companies in the same industry (SIC: 2834)
Investor Resources
Learn more about SEC filings and how to research public companies.
What is the SEC?
A plain English guide to the Securities and Exchange Commission
Understanding SEC Filings & CIK
How to navigate SEC filings and Central Index Keys
10-K Annual Reports Explained
Everything you need to know about annual reports
S-1 & F-1 IPO Filings
Understanding IPO registration statements
SEC EDGAR Database Guide
How to use the SEC's free filing database
Important Disclaimer
This AI-generated analysis is for informational purposes only and does not constitute financial or investment advice. Always consult with qualified professionals and conduct your own research before making investment decisions.